美国 · 股市与财经 · The Motley Fool
Why Viking Therapeutics needs the cash
Viking Therapeutics raised $575 million to fund major obesity drug trials, develop its pipeline, and support commercial development of any approvals for VK2735.
在 The Motley Fool 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.fool.com)




